Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 7
Submit an article Journal homepage
217
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Research

Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies

Gina L. MazzaMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5305-6193View further author information
ORCID Icon,
Katie L. KunzeMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; View further author information
,
Blake T. LanglaisMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; View further author information
,
Heidi E. KosiorekMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; View further author information
,
Todd A. DeWeesMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; View further author information
,
Holly L. GeyerMayo Clinic, Internal Medicine, Phoenix, AZ, USA; View further author information
,
Robyn M. ScherberMays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
,
Ruben A. MesaMays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
&
Amylou C. DueckMayo Clinic, Health Sciences Research, Scottsdale, AZ, USA; View further author information
 show all
Pages 1789-1795 | Received 16 Jun 2018, Accepted 10 Nov 2018, Published online: 17 Jan 2019

References

  • Geyer HL, Dueck AC, Scherber RM, et al. Impact of inflammation on myeloproliferative neoplasm symptom development. Mediators Inflamm. 2015;2015:1–9.
  • Mesa RA, Schwager S, Radia D, et al. The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res. 2009;33:1199–1203.
  • Scherber R, Dueck AC, Johansson P, et al. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood. 2011;118:401–408.
  • Emanuel RM, Dueck AC, Geyer HL, et al. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. JCO. 2012;30:4098–4103.
  • Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85:1186–1196.
  • Mesa RA, Gotlib J, Gupta V, et al. Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. JCO. 2013;31:1285–1292.
  • Coons SJ, Kothari S, Monz BU, et al. The Patient-Reported Outcome (PRO) Consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther. 2011;90:743–748.
  • Fayers PM, Curran D, Machin D. Incomplete quality of life data in randomized trials: missing items. Stat Med. 1998;17:679–696.
  • Bell ML, Fairclough DL, Fiero MH, et al. Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Res Notes. 2016;9:1–10.
  • Fairclough DL, Cella DF. Functional Assessment of Cancer Therapy (FACT-G): nonresponse to individual questions. Qual Life Res. 1996;5:321–329.
  • Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7:147–177.
  • Mazza GL, Enders CK, Ruehlman LS. Addressing item-level missing data: a comparison of proration and full information maximum likelihood estimation. Multivariate Behav Res. 2015;50:504–519.
  • Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 1987.
  • Enders CK. Applied missing data analysis. New York: Guilford Press; 2010.
  • Gottschall AC, West SG, Enders CK. A comparison of item-level and scale-level multiple imputation for questionnaire batteries. Multivariate Behav Res. 2012;47:1–25.
  • Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
  • SAS Institute Incorporated. The MIANALYZE procedure. SAS/STAT 14.3 user's guide. Cary, NC: SAS Institute Incorporated; 2017.
  • Scherber RM, Kosiorek HE, Senyak Z, et al. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms. Cancer. 2016;122:477–485.
  • Anderson LA, James G, Duncombe AS, et al. Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls. Am J Hematol. 2015;90:864–870.
  • Gowin K, Kosiorek H, Dueck A, et al. Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis. Leuk Res. 2017;60:31–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.